Waddell & Reed Financial’s BeOne Medicines Ltd ONC Stock Holding History

Waddell & Reed Financial’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$49.1M	Buy	141,119 +3,022	+2%	+$1M	0.1%	233
2020 Q4	$35.7M	Buy	138,097 +100	+0.1%	+$27.5K	0.08%	276
2020 Q3	$39.5M	Buy	137,997 +224	+0.2%	+$52.6K	0.09%	238
2020 Q2	$26M	Sell	137,773 -1,625	-1%	-$265K	0.07%	287
2020 Q1	$17.2M	Sell	139,398 -1,488	-1%	-$233K	0.06%	308
2019 Q4	$23.4M	Sell	140,886 -57,590	-29%	-$9.57M	0.06%	323
2019 Q3	$24.3M	Buy	198,476 +1	+0%	+$133	0.06%	303
2019 Q2	$24.6M	Buy	198,475 +40,305	+25%	+$5.12M	0.06%	310
2019 Q1	$20.9M	Hold	158,170	–	–	0.05%	338
2018 Q4	$22.2M	Hold	158,170	–	–	0.06%	315
2018 Q3	$27.2M	Hold	158,170	–	–	0.06%	296
2018 Q2	$24.3M	Buy	158,170 +16,080	+11%	+$2.87M	0.06%	312
2018 Q1	$23.9M	Buy	+142,090	New	+$19.2M	0.05%	309

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Waddell & Reed Financial's ONC Position: Q1 2021 in Review

Waddell & Reed Financial increased its BeOne Medicines Ltd (ONC) stake by 2.2% in Q1 2021, buying an estimated $1M and bringing the position to 141,119 shares worth $49.1M. The position accounts for 0.1% of the portfolio, ranked #233.

Waddell & Reed Financial first reported a position in ONC in Q1 2018 and has held it in 13 quarters since. 253 funds tracked by Wall St. Rank hold ONC as of Q1 2021.

Waddell & Reed Financial held 141,119 shares of BeOne Medicines Ltd worth $49.1M as of Q1 2021.
Waddell & Reed Financial bought 3,022 BeOne Medicines Ltd shares in Q1 2021, an estimated $1M.
BeOne Medicines Ltd made up 0.1% of Waddell & Reed Financial's portfolio in Q1 2021, its #233 holding.
Waddell & Reed Financial first reported a position in BeOne Medicines Ltd in Q1 2018 and has held it in 13 quarters since.
253 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.